BRENTWOOD, Tenn., Feb. 18, 2026 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter and full year ended December 31, 2025, which are consistent with the preliminary results announced on January 28, 2026. HIGHLIGHTS (1) "Brookdale's fourth quarter results continued the positive momentum displayed throughout 2025, as we position Brookdale to capitalize on increasing industry demand in a suppressed supply growth environment," said Nick Steng ...

Company Performance - Biofrontera Inc. (BFRI) has returned 55.7% year-to-date, significantly outperforming the average return of 4.3% for Medical companies [4] - The Zacks Consensus Estimate for BFRI's full-year earnings has increased by 700% over the past 90 days, indicating a strong improvement in analyst sentiment and earnings outlook [3] - Biofrontera Inc. is part of the Medical - Biomedical and Genetics industry, which has an average year-to-date return of 21%, further highlighting BFRI's superior performance [5] Industry Context - The Medical sector consists of 928 individual stocks and is currently ranked 10 in the Zacks Sector Rank [2] - The Medical - Biomedical and Genetics industry includes 449 companies and is ranked 90 in the Zacks Industry Rank [5] - Brookdale Senior Living (BKD), another Medical stock, has returned 38.1% year-to-date and is part of the Medical - Nursing Homes industry, which has a year-to-date return of +7.2% [4][6]

Core Viewpoint - Brookdale Senior Living Inc. is set to release its fourth quarter and full year 2025 financial results on February 18, 2026, followed by a conference call on February 19, 2026, to discuss these results [1]. Company Overview - Brookdale Senior Living Inc. is the leading operator of senior living communities in the United States, managing 584 communities across 41 states and serving approximately 51,000 residents as of December 31, 2025 [3]. - The company offers a range of living options including independent living, assisted living, memory care, and continuing care retirement communities, focusing on empowering seniors to live with dignity and purpose [3]. - Brookdale emphasizes its commitment to enriching the lives of seniors through compassionate care, clinical expertise, and exceptional service, guided by its core values of passion, courage, partnership, and trust [3]. - The company's stock is traded on the New York Stock Exchange under the ticker symbol BKD [3].

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Core Insights - Three stocks in the health care sector are signaling potential warnings for momentum-focused investors as of February 2, 2026 [1] Group 1: Momentum Indicators - The Relative Strength Index (RSI) is a key momentum indicator that compares a stock's performance on days with price increases to days with price decreases, helping traders gauge short-term performance [2] - A stock is generally considered overbought when its RSI exceeds 70, indicating potential caution for investors [2] Group 2: Specific Stocks - Brookdale Senior Living Inc (NYSE:BKD) and Mirum Pharmaceuticals Inc (NASDAQ:MIRM) are highlighted as major overbought stocks in the health care sector [3] - Amicus Therapeutics has seen a significant stock price increase of approximately 139% over the past six months, with a recent RSI value of 80.4, indicating it is overbought [3] - The stock of Amicus Therapeutics closed at $14.29, slightly up by 0.1% on the last trading day, with a 52-week high of $14.38 [3]

Core Insights - Three stocks in the health care sector are signaling potential warnings for momentum-focused investors as of February 2, 2026 [1] Group 1: Momentum Indicators - The Relative Strength Index (RSI) is a key momentum indicator that compares a stock's performance on days with price increases to days with price decreases, helping traders gauge short-term performance [2] - A stock is generally considered overbought when its RSI exceeds 70, indicating potential caution for investors [2] Group 2: Specific Stocks - Brookdale Senior Living Inc (NYSE:BKD) and Mirum Pharmaceuticals Inc (NASDAQ:MIRM) are highlighted as major overbought stocks in the health care sector [3] - Amicus Therapeutics has seen a significant stock increase of approximately 139% over the past six months, with a 52-week high of $14.38 and an RSI value of 80.4, indicating it is overbought [3] - On the last trading day, Amicus Therapeutics' shares closed at $14.29, reflecting a slight gain of 0.1% [3]

Core Insights - Brookdale Senior Living Inc. (NYSE:BKD) experienced a significant stock price increase of 15.83% week-on-week, attributed to strong preliminary earnings results and a 31% price target upgrade from an investment firm [1][4] - The stock reached a nine-year high of $15.06 before closing at $15, up 3.45% on the last trading day [1] Financial Performance - For the full year, Brookdale expects to report revenues of $3.2 billion, reflecting a 3% increase from $3.1 billion in 2024 [2] - The company anticipates a net loss of $263 million, which is a 30% increase from the previous year's loss of $202 million, primarily due to higher non-cash impairment charges of approximately $71 million compared to $8 million in 2024 [2] - Adjusted EBITDA is projected to rise by 19% to $458 million, aligning with the midpoint of previously announced guidance [3] Future Projections - For 2026, Brookdale aims to grow its revenue per available room by 8% to 9%, with an adjusted EBITDA target of $502 million to $516 million [3]

Core Insights - Brookdale Senior Living projects RevPAR growth of 8% to 9% for 2026, with adjusted EBITDA guidance of $502 million to $516 million, and anticipates mid-teen annualized growth in adjusted EBITDA through 2028 [1][6][5] Financial Performance - In 2025, Brookdale reported adjusted EBITDA of $458 million, a 19% year-over-year increase, and achieved adjusted free cash flow positivity for the first time since the pandemic [2][3] - The company generated over $3 billion in revenue in 2025, with consolidated RevPAR increasing by 5.7% due to occupancy gains and pricing increases [2][3] Occupancy and Demographics - Same-community occupancy ended 2025 at a weighted average of 83.5%, with a year-end spot occupancy of 84.5%, and the company aims to surpass pre-COVID occupancy levels in 2026 [3][6] - The U.S. population aged 80 and older is projected to grow at a 4% CAGR for the next 15 years, driving demand for senior housing [9][10] Operating Model and Structure - Brookdale has restructured into six regions to enhance decision-making and accountability, focusing on local market needs [13][14] - The company is investing in staffing and signature care programs to improve execution and service quality [5][15] Capital Allocation and Growth Strategy - Management emphasizes a holistic approach to capital expenditures, targeting comprehensive upgrades rather than piecemeal repairs [16][18] - Brookdale is exploring targeted acquisitions to enhance its market presence and address capacity needs in specific regions [16][19] Industry Position - Brookdale is the largest operator of senior living communities in the U.S. and the third-largest owner of senior housing real estate, with 75% of its units owned and 94% of revenue derived from private pay sources [7][20]

Core Viewpoint - Brookdale Senior Living (BKD) has reached a significant turning point where theoretical macroeconomic trends are translating into tangible financial performance [1] Company Analysis - The company is no longer just a theoretical investment but is showing real-world financial improvements [1] Industry Insights - The focus is on identifying companies within the consumer products sector that exhibit strong brand recognition, solid financials, and growth potential [1]

Core Viewpoint - Brookdale Senior Living (BKD) has reached a significant turning point where macroeconomic theories are translating into tangible financial performance [1] Group 1: Company Performance - The company is no longer just a theoretical entity but is now demonstrating real-world financial results [1] Group 2: Investment Focus - The focus is on identifying companies with strong brand recognition, solid financials, and growth potential within the consumer products sector [1]